SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-20-021457
Filing Date
2020-11-16
Accepted
2020-11-16 11:12:31
Documents
73

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 2909111
2 forms1a_001.jpg GRAPHIC 4599
3 forms1a_003.jpg GRAPHIC 4599
4 ex1-1.htm EX-1.1 382372
5 ex4-1.htm EX-4.1 124683
6 ex4-2.htm EX-4.2 113999
7 ex5-1.htm EX-5.1 19824
8 ex23-1.htm EX-23.1 3449
9 ex5-1_001.jpg GRAPHIC 5081
10 ex5-1_002.jpg GRAPHIC 2377
  Complete submission text file 0001493152-20-021457.txt   7984833

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE lixt-20200930.xml EX-101.INS 961932
12 XBRL SCHEMA FILE lixt-20200930.xsd EX-101.SCH 65615
13 XBRL CALCULATION FILE lixt-20200930_cal.xml EX-101.CAL 44679
14 XBRL DEFINITION FILE lixt-20200930_def.xml EX-101.DEF 294585
15 XBRL LABEL FILE lixt-20200930_lab.xml EX-101.LAB 365365
16 XBRL PRESENTATION FILE lixt-20200930_pre.xml EX-101.PRE 363081
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-248588 | Film No.: 201314611
SIC: 2834 Pharmaceutical Preparations